Infusion is used in greater than 90% of hospital treatments, with over $10B sales per year. Yet, infusion systems suffer from an alarming limitation: they are unable to determine the drug flowing through them, flow they create or that flow is entering the patient. Errors due to these limitations account for over 7,000 deaths and over 500,000 adverse drug events per year costing hospitals additional $4B annually. Fluonic solves these problems.